Skip to main content

Animations

MJFF Publications

4291 - 4300 of 8823 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Aβ oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo
    Journal Name: Cell Reports Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xcrm.2022.100630
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Explainable machine learning with pairwise interactions for the classification of Parkinson’s disease and SWEDD from clinical and imaging features
    Journal Name: Brain Imaging and Behavior
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s11682-022-00688-9
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Brain atrophy pattern in de novo Parkinson’s disease with probable RBD associated with cognitive impairment
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00326-7
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00322-x
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Uncovering clinical and radiological asymmetry in progressive supranuclear palsy—Richardson’s syndrome
    Journal Name: Neurological Sciences
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s10072-022-05919-x
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Combining Neuroimaging and Omics Datasets for Disease Classification Using Graph Neural Networks
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2022.866666
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Differentially targeted seeding reveals unique pathological alpha-synuclein propagation patterns
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awab440
    Citation Count: 66
  • Summary Details
    OPEN
    Title: Comparison of Chinese and American subjects on the self‐administered Waterless Empirical Taste Test
    Journal Name: Journal of Sensory Studies
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/joss.12745
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Cathepsin B p.Gly284Val Variant in Parkinson’s Disease Pathogenesis
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms23137086
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Plcg2M28L Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer’s Disease-Relevant Phenotypes in Mice
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.886575
    Citation Count: 22
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.